SARS-CoV-2 RNA (COVID-19) and Influenza A and B, Qualitative NAAT : 31688

Test Code
CVFLMX or 31688

Alias/See Also
SARS, Novel Coronavirus, nCOV, COVID-19, COVID, Wuhan, Coronavirus

CPT Codes
87631

Instructions
One (1) nasopharyngeal (NP) swab collected in VCM (UTM) medium tube, UTM-RT or equivalent Viral Transport Media (VTM) or Phosphate Buffered Saline (PBS)
OR
One (1) nasal (Anterior Nares) swab collected in VCM (UTM) medium tube or equivalent Viral Transport Media (VTM) or 0.9% physiological Saline or Phosphate Buffered Saline (PBS)

Transport Container
Each specimen transport vial that is submitted should be accompanied by its own separate requisition and transported in its own sealed bag.

Transport Temperature
Refrigerated.

Specimen Stability
VCM/UTM, UTM-RT medium or BD UVT or equivalent: 
Room temperature: 7 days; Refrigerated: 14 days; Frozen: 30 days
0.9% physiological saline:
Room temperature: 7 days; Refrigerated: 14 days; Frozen: 7 days
Phosphate Buffered Saline (PBS):
Room temperature: 7 days; Refrigerated: 14 days; Frozen: Unacceptable

Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Calcium alginate swabs, Cotton swabs with wooden shaft, Amies liquid or gel transport used for bacterial cultures

Methodology
Nucleic Acid Amplification Test includes Polymerase Chain Reaction or Transcription Mediated Amplification

Setup Schedule
Sunday - Saturday

Report Available
1-2 days

Reference Range
Not Detected
  
Result Interpretation:
 
A Detected result indicates that RNA from SARS-CoV-2, influenza A, or influenza B was Detected. Clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Test results will be reported to the appropriate public health authorities.
 
A Not Detected (negative) test result for this test means that RNA from SARS-CoV-2, influenza A and influenza B was not present in the specimen above the limit of detection. However, it does not rule out the possibility of infection from SARS-CoV-2, influenza A, and/or influenza B and should not be used as the sole basis for patient management decisions.
 
An Inconclusive result for SARS-CoV-2 means not all of the testing targets were detected. This could be due to a sample with viral concentrations near the limit of detection of the test or other factors. An additional sample collection may be considered.
 
Laboratory test results should always be considered in the context of clinical observations and epidemiological data in making a final diagnosis and patient management decisions.

Clinical Significance
SARS-CoV-2 RNA (COVID-19) and Influenza A and B, Qualitative NAAT is a qualitative multi-target molecular diagnostic test that aids in simultaneous detection of COVID-19, influenza A and influenza B. This test is intended to be performed on respiratory specimens collected by a healthcare provider from individuals suspected of respiratory viral infection consistent with COVID-19 or influenza.

Performing Laboratory
med fusion



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.